CureVac News

GSK Reveals 'Positive' Data From Mid-Stage Study Of Seasonal Influenza MRNA Vaccine

BenzingaSep 12 11:32 ET

GSK's HSV Vaccine Study Fails to Meet Primary Efficacy Goal

Zacks Sep 12 11:00 ET

GSK, CureVac MRNA Flu Shot Reaches Late-stage Studies

Seeking AlphaSep 12 08:01 ET

Express News | CureVac NV Says : CureVac Partner GSK Announces Positive Phase 2 Data From Seasonal Influenza Mrna Vaccine Program

ReutersSep 12 06:58 ET

CureVac Unveils Promising Glioblastoma Vaccine Data

TipRanksSep 9 16:47 ET

Deutsche Bank Maintains CureVac(CVAC.US) With Hold Rating, Cuts Target Price to $3.9

Moomoo NewsSep 2 09:31 ET · Ratings

CureVac (CVAC) Receives a Hold From Deutsche Bank

TipRanksSep 2 08:35 ET · Ratings

We're Hopeful That CureVac (NASDAQ:CVAC) Will Use Its Cash Wisely

Simply Wall StSep 2 08:10 ET

Analysts Offer Insights on Healthcare Companies: CureVac (CVAC), Vericel (VCEL) and Twist Bioscience (TWST)

TipRanksAug 20 03:10 ET · Ratings

CureVac Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Yahoo FinanceAug 18 08:28 ET

Express News | JMP Securities Maintains Market Outperform on CureVac, Lowers Price Target to $16

BenzingaAug 16 08:02 ET

CureVac Analyst Ratings

BenzingaAug 16 08:01 ET · Ratings

JMP Securities Maintains CureVac(CVAC.US) With Buy Rating, Cuts Target Price to $16

Moomoo NewsAug 16 00:31 ET · Ratings

CureVac: A Promising Buy Amidst Financial Stability and Innovative Vaccine Pipeline

TipRanksAug 16 00:25 ET

CureVac Secures Lucrative GSK Deal and Refocuses Business

TipRanksAug 15 16:57 ET

CureVac's Rising Revenues Met With Increased Losses

TipRanksAug 15 16:48 ET

CureVac's Cancer Vaccine Enters Next Trial Phase

TipRanksAug 15 16:47 ET

CureVac Welcomes New Expert to Supervisory Board

TipRanksAug 15 16:47 ET

CureVac | 6-K: Report of foreign private issuer (related to financial reporting)

SECAug 15 16:27 ET · Announcements

Sector Update: Health Care Stocks Flat to Higher Premarket Thursday

MT NewswiresAug 15 09:06 ET